Log in

NASDAQ:SWAV - Shockwave Medical Stock Price, Forecast & News

$44.35
-3.39 (-7.10 %)
(As of 02/16/2020 03:04 PM ET)
Add
Today's Range
$42.94
Now: $44.35
$46.83
50-Day Range
$42.16
MA: $44.17
$47.74
52-Week Range
$24.58
Now: $44.35
$68.39
Volume1.39 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SWAV
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees162
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.


Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How were Shockwave Medical's earnings last quarter?

Shockwave Medical Inc (NASDAQ:SWAV) posted its quarterly earnings results on Thursday, February, 13th. The company reported ($0.49) EPS for the quarter, beating the Zacks' consensus estimate of ($0.51) by $0.02. The firm had revenue of $14.31 million for the quarter, compared to analysts' expectations of $13.34 million. View Shockwave Medical's Earnings History.

When is Shockwave Medical's next earnings date?

Shockwave Medical is scheduled to release their next quarterly earnings announcement on Wednesday, May 13th 2020. View Earnings Estimates for Shockwave Medical.

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical issued an update on its FY 2020 After-Hours earnings guidance on Thursday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.34 million.

What price target have analysts set for SWAV?

7 analysts have issued 12 month price targets for Shockwave Medical's stock. Their forecasts range from $44.00 to $54.00. On average, they expect Shockwave Medical's share price to reach $48.17 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price. View Analyst Price Targets for Shockwave Medical.

What is the consensus analysts' recommendation for Shockwave Medical?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Shockwave Medical.

Has Shockwave Medical been receiving favorable news coverage?

News stories about SWAV stock have trended neutral on Sunday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Shockwave Medical earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Shockwave Medical.

Are investors shorting Shockwave Medical?

Shockwave Medical saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 3,860,000 shares, a decrease of 7.2% from the January 15th total of 4,160,000 shares. Based on an average daily volume of 532,700 shares, the days-to-cover ratio is currently 7.2 days. Currently, 18.0% of the shares of the company are short sold. View Shockwave Medical's Current Options Chain.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Paypal (PYPL), Twilio (TWLO), Walt Disney (DIS), Home Depot (HD), Veeva Systems (VEEV), Trade Desk (TTD) and Guardant Health (GH).

Who are Shockwave Medical's key executives?

Shockwave Medical's management team includes the folowing people:
  • Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
  • Mr. Daniel Puckett, CFO & Sec. (Age 55)
  • Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
  • Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
  • Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (16.49%), Alpine Global Management LLC (2.56%), Jennison Associates LLC (2.05%), State Street Corp (1.53%), Lord Abbett & CO. LLC (1.42%) and Point72 Asset Management L.P. (0.62%). Company insiders that own Shockwave Medical stock include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias, James E Flynn and Sofinnova Capital Vii Fcpr. View Institutional Ownership Trends for Shockwave Medical.

Which major investors are selling Shockwave Medical stock?

SWAV stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Alyeska Investment Group L.P., Goldman Sachs Group Inc., Cubist Systematic Strategies LLC and NumerixS Investment Technologies Inc. Company insiders that have sold Shockwave Medical company stock in the last year include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias and Sofinnova Capital Vii Fcpr. View Insider Buying and Selling for Shockwave Medical.

Which major investors are buying Shockwave Medical stock?

SWAV stock was acquired by a variety of institutional investors in the last quarter, including Alpine Global Management LLC, FMR LLC, State Street Corp, Jennison Associates LLC, Lord Abbett & CO. LLC, Point72 Asset Management L.P., WCM Investment Management LLC and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Shockwave Medical.

How do I buy shares of Shockwave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $44.35.


MarketBeat Community Rating for Shockwave Medical (NASDAQ SWAV)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  61 (Thanks for Voting!)
Underperform Votes:  71 (Thanks for Voting!)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote "Outperform" if you believe SWAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel